retatrutide spray 5ML Nasal RETATRUTIDE + CAGRILINTIDE – Research

After promising results, large-scale Phase III trials (the SUSTAIN program) were launched around 2015

Larger-scale federally licensed compounders (503B outsourcing facilities) have until March 19, 2025, to wind down their production and distribution of compounded tirzepatide

Wegovy uniquely carries SELECT-trial cardiovascular risk reduction data, a label most Indian generics do not yet carry

Discrepancies in mortality-related outcomes could be due to differences in follow-up periods and study population

Although the percentage of antidiabetes medication usage was higher in the placebo group, the difference was not statistically significant (p = 0.097)